In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AdaptHealth Corp. trades significantly below its high-confidence fair value estimate of $38.52, indicating substantial upside potential. However, poor financial health scores and extreme Monte Carlo volatility (CV 177%) highlight elevated operational and valuation risk. The zero downside risk in simulations suggests current pricing may already discount financial weaknesses.